This report contains market size and forecasts of Epilepsy Drug in global, including the following market information:
Global Epilepsy Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Epilepsy Drug Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Epilepsy Drug companies in 2020 (%)
The global Epilepsy Drug market was valued at 1892.4 million in 2020 and is projected to reach US$ 1997.1 million by 2027, at a CAGR of 1.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epilepsy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epilepsy Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Epilepsy Drug Market Segment Percentages, By Type, 2020 (%)
First Generation Drugs
Second Generation Drugs
Third Generation Drugs
Global Epilepsy Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Epilepsy Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others
Global Epilepsy Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Epilepsy Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epilepsy Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Epilepsy Drug revenues share in global market, 2020 (%)
Key companies Epilepsy Drug sales in global market, 2016-2021 (Estimated), (MT)
Key companies Epilepsy Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Eisai
Novartis
Sanofi
Union Chimique Belge
Abbott
GlaxoSmithKline
Sunovion Pharmaceuticals
Teva Pharmaceutical
Johnson & Johnson
Abbvie
Janssen Pharmaceuticals
Cephalon
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Epilepsy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epilepsy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epilepsy Drug Overall Market Size
2.1 Global Epilepsy Drug Market Size: 2021 VS 2027
2.2 Global Epilepsy Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Epilepsy Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Epilepsy Drug Players in Global Market
3.2 Top Global Epilepsy Drug Companies Ranked by Revenue
3.3 Global Epilepsy Drug Revenue by Companies
3.4 Global Epilepsy Drug Sales by Companies
3.5 Global Epilepsy Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Epilepsy Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Epilepsy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Epilepsy Drug Players in Global Market
3.8.1 List of Global Tier 1 Epilepsy Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Epilepsy Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Epilepsy Drug Market Size Markets, 2021 & 2027
4.1.2 First Generation Drugs
4.1.3 Second Generation Drugs
4.1.4 Third Generation Drugs
4.2 By Type - Global Epilepsy Drug Revenue & Forecasts
4.2.1 By Type - Global Epilepsy Drug Revenue, 2016-2021
4.2.2 By Type - Global Epilepsy Drug Revenue, 2022-2027
4.2.3 By Type - Global Epilepsy Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Epilepsy Drug Sales & Forecasts
4.3.1 By Type - Global Epilepsy Drug Sales, 2016-2021
4.3.2 By Type - Global Epilepsy Drug Sales, 2022-2027
4.3.3 By Type - Global Epilepsy Drug Sales Market Share, 2016-2027
4.4 By Type - Global Epilepsy Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Epilepsy Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Epilepsy Drug Revenue & Forecasts
5.2.1 By Application - Global Epilepsy Drug Revenue, 2016-2021
5.2.2 By Application - Global Epilepsy Drug Revenue, 2022-2027
5.2.3 By Application - Global Epilepsy Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Epilepsy Drug Sales & Forecasts
5.3.1 By Application - Global Epilepsy Drug Sales, 2016-2021
5.3.2 By Application - Global Epilepsy Drug Sales, 2022-2027
5.3.3 By Application - Global Epilepsy Drug Sales Market Share, 2016-2027
5.4 By Application - Global Epilepsy Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Epilepsy Drug Market Size, 2021 & 2027
6.2 By Region - Global Epilepsy Drug Revenue & Forecasts
6.2.1 By Region - Global Epilepsy Drug Revenue, 2016-2021
6.2.2 By Region - Global Epilepsy Drug Revenue, 2022-2027
6.2.3 By Region - Global Epilepsy Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Epilepsy Drug Sales & Forecasts
6.3.1 By Region - Global Epilepsy Drug Sales, 2016-2021
6.3.2 By Region - Global Epilepsy Drug Sales, 2022-2027
6.3.3 By Region - Global Epilepsy Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Epilepsy Drug Revenue, 2016-2027
6.4.2 By Country - North America Epilepsy Drug Sales, 2016-2027
6.4.3 US Epilepsy Drug Market Size, 2016-2027
6.4.4 Canada Epilepsy Drug Market Size, 2016-2027
6.4.5 Mexico Epilepsy Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Epilepsy Drug Revenue, 2016-2027
6.5.2 By Country - Europe Epilepsy Drug Sales, 2016-2027
6.5.3 Germany Epilepsy Drug Market Size, 2016-2027
6.5.4 France Epilepsy Drug Market Size, 2016-2027
6.5.5 U.K. Epilepsy Drug Market Size, 2016-2027
6.5.6 Italy Epilepsy Drug Market Size, 2016-2027
6.5.7 Russia Epilepsy Drug Market Size, 2016-2027
6.5.8 Nordic Countries Epilepsy Drug Market Size, 2016-2027
6.5.9 Benelux Epilepsy Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Epilepsy Drug Revenue, 2016-2027
6.6.2 By Region - Asia Epilepsy Drug Sales, 2016-2027
6.6.3 China Epilepsy Drug Market Size, 2016-2027
6.6.4 Japan Epilepsy Drug Market Size, 2016-2027
6.6.5 South Korea Epilepsy Drug Market Size, 2016-2027
6.6.6 Southeast Asia Epilepsy Drug Market Size, 2016-2027
6.6.7 India Epilepsy Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Epilepsy Drug Revenue, 2016-2027
6.7.2 By Country - South America Epilepsy Drug Sales, 2016-2027
6.7.3 Brazil Epilepsy Drug Market Size, 2016-2027
6.7.4 Argentina Epilepsy Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Epilepsy Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Epilepsy Drug Sales, 2016-2027
6.8.3 Turkey Epilepsy Drug Market Size, 2016-2027
6.8.4 Israel Epilepsy Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Epilepsy Drug Market Size, 2016-2027
6.8.6 UAE Epilepsy Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Epilepsy Drug Major Product Offerings
7.1.4 Pfizer Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Epilepsy Drug Major Product Offerings
7.2.4 Eisai Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.2.5 Eisai Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Epilepsy Drug Major Product Offerings
7.3.4 Novartis Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Epilepsy Drug Major Product Offerings
7.4.4 Sanofi Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 Union Chimique Belge
7.5.1 Union Chimique Belge Corporate Summary
7.5.2 Union Chimique Belge Business Overview
7.5.3 Union Chimique Belge Epilepsy Drug Major Product Offerings
7.5.4 Union Chimique Belge Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.5.5 Union Chimique Belge Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Epilepsy Drug Major Product Offerings
7.6.4 Abbott Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.6.5 Abbott Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Epilepsy Drug Major Product Offerings
7.4.4 GlaxoSmithKline Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.7.5 GlaxoSmithKline Key News
7.8 Sunovion Pharmaceuticals
7.8.1 Sunovion Pharmaceuticals Corporate Summary
7.8.2 Sunovion Pharmaceuticals Business Overview
7.8.3 Sunovion Pharmaceuticals Epilepsy Drug Major Product Offerings
7.8.4 Sunovion Pharmaceuticals Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.8.5 Sunovion Pharmaceuticals Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Epilepsy Drug Major Product Offerings
7.9.4 Teva Pharmaceutical Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.9.5 Teva Pharmaceutical Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Epilepsy Drug Major Product Offerings
7.10.4 Johnson & Johnson Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.10.5 Johnson & Johnson Key News
7.11 Abbvie
7.11.1 Abbvie Corporate Summary
7.11.2 Abbvie Epilepsy Drug Business Overview
7.11.3 Abbvie Epilepsy Drug Major Product Offerings
7.11.4 Abbvie Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.11.5 Abbvie Key News
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Corporate Summary
7.12.2 Janssen Pharmaceuticals Epilepsy Drug Business Overview
7.12.3 Janssen Pharmaceuticals Epilepsy Drug Major Product Offerings
7.12.4 Janssen Pharmaceuticals Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.12.5 Janssen Pharmaceuticals Key News
7.13 Cephalon
7.13.1 Cephalon Corporate Summary
7.13.2 Cephalon Epilepsy Drug Business Overview
7.13.3 Cephalon Epilepsy Drug Major Product Offerings
7.13.4 Cephalon Epilepsy Drug Sales and Revenue in Global (2016-2021)
7.13.5 Cephalon Key News
8 Global Epilepsy Drug Production Capacity, Analysis
8.1 Global Epilepsy Drug Production Capacity, 2016-2027
8.2 Epilepsy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Epilepsy Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Epilepsy Drug Supply Chain Analysis
10.1 Epilepsy Drug Industry Value Chain
10.2 Epilepsy Drug Upstream Market
10.3 Epilepsy Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Epilepsy Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Epilepsy Drug in Global Market
Table 2. Top Epilepsy Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Epilepsy Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Epilepsy Drug Revenue Share by Companies, 2016-2021
Table 5. Global Epilepsy Drug Sales by Companies, (MT), 2016-2021
Table 6. Global Epilepsy Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Epilepsy Drug Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Epilepsy Drug Product Type
Table 9. List of Global Tier 1 Epilepsy Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epilepsy Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type